Q5152 – Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg

Long description

Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg

Short description

Inj, eculizumab-aeeb, 2 mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

April 1, 2025

Last change

July 1, 2025 – No change

Nearby Q codes

• Q5144 – Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
• Q5145 – Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
• Q5146 – Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
• Q5147 – Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
• Q5148 – Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
• Q5149 – Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
• Q5150 – Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
• Q5151 – Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
• Q5153 – Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
• Q5154 – Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
• Q5155 – Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
• Q5156 – Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
• Q5157 – Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
• Q5158 – Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
• Q5159 – Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
• Q5160 – Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg